FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with...
Vous n'êtes pas connecté
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to...
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with...
Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...
TUESDAY, June 18, 2024 -- Among adult patients undergoing cardiac surgery, infusion of amino acids reduces the occurrence of acute kidney injury...
In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...
A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated...
Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...
New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.
THURSDAY, June 20, 2024 -- Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to...
MONDAY, June 17, 2024 -- For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater...
TUESDAY, June 18, 2024 -- A multimodal intervention trial implementing evidence-based practice strategies does not reduce opioid overdose deaths,...